Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
267.50    16.50 (6.57%)
Bid:
265.00
Ask:
270.00
Spread: 5.00 (1.887%)
Market Cap: £243.00m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Director Share Dealing

28 Feb 2025 07:00

RNS Number : 7962Y
Concurrent Technologies PLC
28 February 2025
 

28 February 2025

Concurrent Technologies Plc

(the "Company" or the "Group")

Director Share Dealing

 

Concurrent Technologies PLC (AIM: CNC), a designer and manufacturer of leading-edge computer products, systems and mission critical solutions used in high-performance markets by some of the world's major OEMs, announces that Brent Salgat, Director & Chief Revenue Officer, has sold 40,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at an average price of 166.8p to cover associated tax liabilities from his exercise of 150,000 share options, as notified on 13th September 2024.

 

Following the sale of the Ordinary Shares, Mr Salgat has a total interest in 110,000 Ordinary Shares, representing 0.13 per cent of the Company's issued share capital.

 

Enquiries:

 

Concurrent Technologies Plc Miles Adcock - CEO

Kim Garrod - CFO

 

+44 (0)1206 752626

 

Alma Strategic Communications Josh Royston

Hannah Campbell

 

+44 (0)20 3405 0205

 

Cavendish Capital Markets Limited (NOMAD) Neil McDonald

Peter Lynch

 

+44 (0)131 220 9771

+44 (0)131 220 9772

About Concurrent Technologies Plc

Concurrent Technologies Plc develops and manufactures high-end embedded Plug In Cards and Systems for use in a wide range of high performance, long life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products feature Intel® processors, including the latest generation embedded Intel® Core™ processors, Intel® Xeon® and Intel Atom™ processors. The products are designed to be compliant with industry specifications and support many of today's leading embedded Operating Systems. The products are sold world-wide.

For more information on Concurrent Technologies Plc and its products please visit www.gocct.com.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Brent Salgat

2.

Reason for the Notification

a)

Position/status

Chief Revenue Officer & Executive Director

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Concurrent Technologies Plc

b)

LEI

213800422HXP2X6UPD94

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 1 pence each

Identification code

GB0002183191

b)

Nature of the Transaction

Exercise of Options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

167 pence

30,000 ordinary shares

US$2.10 (166.48 pence)

10,000 ordinary shares

d)

Aggregated information

Aggregated volume price

N/A - Single Transaction

e)

Date of the transaction

26 February 2025

f)

Place of the transaction

AIM, London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAEAXAFFSEAA
Date   Source Headline
27th Jun 200612:00 pmPRNTrading Statement
22nd May 20062:03 pmRNSHolding(s) in Company
17th May 20067:00 amRNSHolding(s) in Company
28th Apr 20067:00 amPRNAGM Statement
10th Apr 200611:45 amPRNProduct Launch
21st Mar 200612:41 pmRNSDirector/PDMR Shareholding
16th Mar 20066:03 pmRNSHolding(s) in Company
10th Mar 20061:27 pmRNSHolding(s) in Company
6th Mar 20067:00 amPRNFinal Results
21st Feb 200611:16 amPRNNotice of Results
1st Feb 200610:40 amPRNProduct Launch
11th Jan 20067:00 amPRNProduct Launch
6th Dec 20053:53 pmRNSTrading Statement
17th Nov 20054:58 pmRNSHolding(s) in Company
1st Nov 20057:00 amPRNProduct Launch
27th Oct 20057:00 amPRNProduct Launch
12th Sep 20053:25 pmRNSDirector/PDMR Shareholding
12th Sep 200510:12 amRNSDirector/PDMR Shareholding
5th Sep 20056:00 amPRNInterim Results
23rd Aug 20056:00 amPRNProduct Launch
16th Aug 20054:15 pmPRNNotice of Results
27th Jul 20051:29 pmRNSShareholder Notification
6th Jul 200511:25 amPRNProduct Launch
30th Jun 20052:30 pmPRNProduct Launch
10th Jun 20055:21 pmRNSProduct Launch
31st May 20053:44 pmRNSDirector Shareholding
24th May 20054:20 pmRNSDirector Shareholding
29th Apr 20054:33 pmRNSAGM Statement
13th Apr 20051:20 pmRNSProduct Launch
4th Apr 20054:02 pmRNSDirector Shareholding
4th Apr 20054:00 pmRNSDirector Shareholding
30th Mar 20054:59 pmRNSDirector Shareholding
22nd Mar 20055:45 pmRNSHolding(s) in Company
21st Mar 20053:00 pmRNSHolding(s) in Company
14th Mar 20057:01 amRNSProduct Launch
7th Mar 20057:01 amRNSFinal Results
7th Mar 20057:00 amRNSGeographical Expansion
25th Feb 20059:25 amRNSProduct Launch
21st Feb 200512:19 pmRNSNotice of Results
2nd Feb 20057:00 amRNSProduct Launch

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.